SE8305422D0 - Foreningar med farmakologisk verkan, bland annat analgetisk verkan - Google Patents

Foreningar med farmakologisk verkan, bland annat analgetisk verkan

Info

Publication number
SE8305422D0
SE8305422D0 SE8305422A SE8305422A SE8305422D0 SE 8305422 D0 SE8305422 D0 SE 8305422D0 SE 8305422 A SE8305422 A SE 8305422A SE 8305422 A SE8305422 A SE 8305422A SE 8305422 D0 SE8305422 D0 SE 8305422D0
Authority
SE
Sweden
Prior art keywords
effects
associations
pharmacological
analgetic
oxygen atom
Prior art date
Application number
SE8305422A
Other languages
English (en)
Swedish (sv)
Other versions
SE8305422L (sv
Inventor
T H Althuis
C A Harbert
M R Johnsson
Jr L S Melvin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE8305422D0 publication Critical patent/SE8305422D0/xx
Publication of SE8305422L publication Critical patent/SE8305422L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/48Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/59Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
SE8305422A 1977-09-13 1983-10-03 Foreningar med farmakologisk verkan, bland annat analgetisk verkan SE8305422L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/832,869 US4147872A (en) 1977-09-13 1977-09-13 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor

Publications (2)

Publication Number Publication Date
SE8305422D0 true SE8305422D0 (sv) 1983-10-03
SE8305422L SE8305422L (sv) 1983-10-03

Family

ID=25262819

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7809606A SE7809606L (sv) 1977-09-13 1978-09-12 Foreningar med analgetisk aktivitet, nemligen 3-(2-hydroxi-4-(substituerad)fenyl)-azacykloalkaner och derivat derav jemte mellanprodukter for deras framstellning
SE8305422A SE8305422L (sv) 1977-09-13 1983-10-03 Foreningar med farmakologisk verkan, bland annat analgetisk verkan

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7809606A SE7809606L (sv) 1977-09-13 1978-09-12 Foreningar med analgetisk aktivitet, nemligen 3-(2-hydroxi-4-(substituerad)fenyl)-azacykloalkaner och derivat derav jemte mellanprodukter for deras framstellning

Country Status (23)

Country Link
US (1) US4147872A (xx)
JP (5) JPS5935397B2 (xx)
AR (2) AR222019A1 (xx)
AT (1) AT368753B (xx)
AU (1) AU507953B1 (xx)
BE (1) BE870403A (xx)
CA (1) CA1113463A (xx)
CH (1) CH638187A5 (xx)
DE (1) DE2839883A1 (xx)
DK (1) DK401078A (xx)
ES (2) ES473287A1 (xx)
FI (1) FI66173C (xx)
FR (4) FR2401913A1 (xx)
GB (1) GB2004548B (xx)
IE (1) IE47717B1 (xx)
IL (1) IL55555A (xx)
IT (1) IT1099026B (xx)
LU (1) LU80219A1 (xx)
NL (1) NL7809272A (xx)
PH (1) PH15372A (xx)
PT (1) PT68542A (xx)
SE (2) SE7809606L (xx)
YU (1) YU215678A (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
FI792076A (fi) * 1978-07-05 1980-01-06 Ciba Geigy Ag Foerfarande foer framstaellning av nya fenylpiperidinderivat
US4302590A (en) * 1979-02-23 1981-11-24 Hoechst-Roussel Pharmaceuticals, Inc. Intermediates for the preparation of 4-aryloxy-3-phenylpiperidines
US4312876A (en) * 1979-02-23 1982-01-26 Hoechst-Roussel Pharmaceuticals Incorporated Antidepressive and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
US4216218A (en) * 1979-02-23 1980-08-05 American Hoechst Corporation Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
ZA821888B (en) * 1981-04-01 1983-02-23 Haessle Ab Novel phenyl-piperidines
US4709016A (en) * 1982-02-01 1987-11-24 Northeastern University Molecular analytical release tags and their use in chemical analysis
US4529732A (en) * 1983-03-14 1985-07-16 Pfizer Inc. 2-[2-Hydroxy-4-(substituted)phenyl]piperidines
FI864570A0 (fi) * 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2495903A1 (en) * 2002-08-23 2004-03-04 University Of Connecticut Novel biphenyl and biphenyl-like cannabinoids
DE102004036349A1 (de) * 2004-07-27 2006-03-23 Grünenthal GmbH Substituierte 3-Phenylpiperidin-Derivate
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
EA024559B1 (ru) 2009-05-06 2016-09-30 Лаборэтори Скин Кэа, Инк. Композиции для нанесения на кератинизированную поверхность кожи млекопитающего и способ доставки
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CA2900309A1 (fr) * 2013-02-14 2014-08-21 Galderma Research & Development Procede de synthese de 4-piperidin-4-yl-benzene-1,3-diol et de ses sels et nouveau compose 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate de tert-butyle

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310761A1 (fr) * 1975-05-16 1976-12-10 Roussel Uclaf Nouveaux derives de la phenyl-piperidine et leurs sels, procede de preparation et application a titre de medicaments

Also Published As

Publication number Publication date
DK401078A (da) 1979-03-14
JPS5538365A (en) 1980-03-17
FI66173B (fi) 1984-05-31
JPS5492973A (en) 1979-07-23
FR2412531B1 (xx) 1983-01-14
JPS5935397B2 (ja) 1984-08-28
AT368753B (de) 1982-11-10
GB2004548A (en) 1979-04-04
CH638187A5 (fr) 1983-09-15
IE781837L (en) 1979-03-13
DE2839883A1 (de) 1979-03-15
BE870403A (fr) 1979-03-12
IL55555A0 (en) 1978-12-17
FR2412531A1 (fr) 1979-07-20
FR2412529B1 (xx) 1983-01-14
FR2412530A1 (fr) 1979-07-20
PH15372A (en) 1982-12-10
LU80219A1 (fr) 1980-04-21
FR2412530B1 (xx) 1982-11-12
JPS5640155B2 (xx) 1981-09-18
IT7827557A0 (it) 1978-09-12
AU507953B1 (en) 1980-03-06
IL55555A (en) 1982-08-31
YU215678A (en) 1983-06-30
AR220567A1 (es) 1980-11-14
IT1099026B (it) 1985-09-18
SE7809606L (sv) 1979-03-14
CA1113463A (en) 1981-12-01
JPS5495577A (en) 1979-07-28
FI782793A (fi) 1979-03-14
FR2401913B1 (xx) 1983-01-21
FR2412529A1 (fr) 1979-07-20
IE47717B1 (en) 1984-05-30
GB2004548B (en) 1982-03-24
SE8305422L (sv) 1983-10-03
JPS5463086A (en) 1979-05-21
US4147872A (en) 1979-04-03
PT68542A (en) 1978-10-01
ES473287A1 (es) 1980-03-01
NL7809272A (nl) 1979-03-15
ES480151A1 (es) 1980-04-01
JPS5538366A (en) 1980-03-17
FI66173C (fi) 1984-09-10
AR222019A1 (es) 1981-04-15
FR2401913A1 (fr) 1979-03-30
ATA658078A (de) 1982-03-15

Similar Documents

Publication Publication Date Title
SE8305422D0 (sv) Foreningar med farmakologisk verkan, bland annat analgetisk verkan
BG30015A3 (en) Method for obtaining of triphenylalkene derivatives
DK463388D0 (da) Mellemprodukter til fremstilling af phenanthrenderivater
PL206019A1 (pl) Sposob wytwarzania nowych pochodnych benzimidazolu jako skaldnikow pasozytobojczych
FR2377392A1 (fr) Nouveaux medicaments derives de la meta-trifluoromethyl-phenylpiperazine
NO881616D0 (no) Middel til innsekts- og middbekjempelse.
SE8003228L (sv) Nya derivat av 5h-furanon-2 och 3h-dihydrofuranon-2, deras framstellningssett och terapeutiska anvendning
SE7608545L (sv) Tiazolidinderivat och forfarande for deras framstellning
JPS5430184A (en) 3,4-dihydrocarbostyril derivative
RO78871B (ro) Procedeu pentru prepararea unor derivati de piridiluree si piridiltiouree
JPS5430183A (en) 3,4-dihydrocarbostyril derivative
SE457086B (sv) Erytromycin a-derivat till anvaendning som mellanprodukter foer framstaellning av terapeutiska anvaendbara derivat av 4"-desoxy-4"-aminoerytromycin a
BG41818A3 (en) Method for preparing 9- hydroxyetoxymethyl guanidine derivative
SE417583B (sv) Bultpistol med en forlengning, som er vinkelret mot pipans axel
ES451451A1 (es) Un procedimiento para la preparacion de nuevos derivados de iminoacetamida.
BG35040A3 (en) Method for preparing a benzoimic derivative of 2- (2, 6'- dichlorphenylamino)- 2- imidazoline and its salt
FR2373563A1 (fr) 3 a-hydroxy-5b-cholest-24-ene, derives en 3 a de celui-ci et leur procede de preparation
ES318577A1 (es) Procedimiento para la obtencion de derivados de las 3- (8- amino - b -hidroxipropil) - 4 -alquil - 7 - hidroxi-cumarinas
FR2361364A1 (fr) Nouveaux derives d'azetidine
FR2448544A1 (fr) Derives de thiazole et leur application en therapeutique
JPS5430180A (en) 3,4-dihydrocarbostyril derivative
JPS5359664A (en) Novel imidazole derivatives
JPS5412384A (en) Carbostyril derivative
FI780791A (fi) Foerfarande foer framstaellning av nya 3-(1-karboxi-alkoxi)-pyrazol-derivat
FR2386541A1 (fr) Derives du thenoyindane

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8305422-1

Effective date: 19861212